[Effect of inhibition of the beta-adrenergic receptors on changes of blood sugar, and free fatty acids and glycerol in the blood, produced by glucagon].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001786:Blood Glucose / Q000096:biosynthesis*; D005227:Fatty Acids / Q000097:blood*; D005260:Female; D005934:Glucagon / Q000494:pharmacology*; D005990:Glycerol / Q000097:blood*; D006801:Humans; D008297:Male; D011433:Propranolol / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D005227:Fatty Acids; D013565:Sympatholytics; D005934:Glucagon; D011433:Propranolol; D005990:Glycerol
L'effet de l'inhibition des récepteurs bêta-adrénergiques, sur les variations de la glycémie, des acides gras libres et du glycérol plasmatique, produites par le glucagon.